{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:08:11Z","timestamp":1790024891754,"version":"4.0.1"},"reference-count":30,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Kuopio University Hospital","award":["Grant"],"award-info":[{"award-number":["Grant"]}]},{"name":"Sanofi-Genzyme","award":["Grant"],"award-info":[{"award-number":["Grant"]}]},{"name":"the Finnish Heart Research Foundation","award":["Grant"],"award-info":[{"award-number":["Grant"]}]},{"DOI":"10.13039\/501100002341","name":"The Academy of Finland","doi-asserted-by":"crossref","award":["Grant"],"award-info":[{"award-number":["Grant"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2019,11,18]]},"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate whether the Ala143Thr variant of the <jats:italic>\u03b1-galactosidase A<\/jats:italic> gene (A143T\/<jats:italic>GLA<\/jats:italic>), with conflicting interpretations of pathogenicity, is associated with Fabry cardiomyopathy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The index patient, a woman in her 60s with cardiomyopathy, was screened for variants in 59 cardiomyopathy-related genes. A143T\/<jats:italic>GLA<\/jats:italic>, the only rare variant found, was screened in 10 relatives. GLA activity and lyso-Gb3 levels were measured and echocardiography was performed in 8 of 9 subjects carrying A143T\/<jats:italic>GLA<\/jats:italic>. Cardiac magnetic resonance (CMR) imaging and <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose (FDG) positron emission tomography\/CT (PET\/CT) were performed in four adult A143T\/<jats:italic>GLA<\/jats:italic> carriers. Endomyocardial biopsy was obtained from two adult A143T\/<jats:italic>GLA<\/jats:italic> carrying sons of the index patient.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The index patient and her elder son had a pacemaker implantation because of sick sinus syndrome and atrioventricular block. GLA activities were decreased to 25%\u201340% of normal in both sons and one granddaughter. Lyso-Gb3 levels were elevated in both sons. In CMR, the index patient and her two sons had left ventricular (LV) hypertrophy and\/or dilatation. The elder son had late gadolinium enhancement, high CMR-derived T1 time and positive FDG signal in PET\/CT in the basal inferolateral LV wall. The younger son had low T1 time and the mother had positive FDG signal in PET\/CT in the basal inferolateral LV wall. Endomyocardial biopsy of both sons showed myocardial accumulation compatible with glycolipids in light and electron microscopy, staining with anti-Gb3 antibody available for the younger son. Five female relatives with A143T\/<jats:italic>GLA<\/jats:italic> had no cardiomyopathy in cardiac imaging.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A143T\/<jats:italic>GLA<\/jats:italic> is likely a late-onset Fabry cardiomyopathy causing variant with incomplete penetrance.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2019-315933","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T17:15:34Z","timestamp":1579194934000},"page":"609-615","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":32,"title":["Cardiomyopathy associated with the Ala143Thr variant of the <i>\u03b1-galactosidase A<\/i> gene"],"prefix":"10.1136","volume":"106","author":[{"given":"Kati","family":"Valtola","sequence":"first","affiliation":[{"name":"Heart Center, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita","family":"Nino-Quintero","sequence":"additional","affiliation":[{"name":"Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"Hedman","sequence":"additional","affiliation":[{"name":"Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Lottonen-Raikaslehto","sequence":"additional","affiliation":[{"name":"Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomi","family":"Laitinen","sequence":"additional","affiliation":[{"name":"Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maleeha","family":"Maria","sequence":"additional","affiliation":[{"name":"Genome Center of Eastern Finland, University of Eastern Finland School of Medicine, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Kantola","sequence":"additional","affiliation":[{"name":"Division of Medicine, Turku University Hospital, Turku, Finland"},{"name":"School of Medicine, University of Turku, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Naukkarinen","sequence":"additional","affiliation":[{"name":"Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Laakso","sequence":"additional","affiliation":[{"name":"Genome Center of Eastern Finland, University of Eastern Finland School of Medicine, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6550-3176","authenticated-orcid":false,"given":"Johanna","family":"Kuusisto","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kuopio University Hospital, Kuopio, Finland"},{"name":"Centre for Medicine and Clinical Research, University of Eastern Finland School of Medicine, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,1,16]]},"reference":[{"key":"2025092100102409000_106.8.609.1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.acvd.2019.01.002","article-title":"Fabry disease in cardiology practice: literature review and expert point of view","volume":"112","author":"Hag\u00e8ge","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"2025092100102409000_106.8.609.2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.063818"},{"key":"2025092100102409000_106.8.609.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.794529"},{"key":"2025092100102409000_106.8.609.4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"2025092100102409000_106.8.609.5","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-300364"},{"key":"2025092100102409000_106.8.609.6","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-014-9452-9"},{"key":"2025092100102409000_106.8.609.7","unstructured":"Kiesling JL . Missouri's full population pilot screening for Fabry disease and the implications for families. Association of Public Health Laboratories, 2014."},{"key":"2025092100102409000_106.8.609.8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10897-017-0139-y","article-title":"The psychosocial impact of carrying a debated variant in the Gla gene","volume":"27","author":"Macklin","year":"2018","journal-title":"J Genet Couns"},{"key":"2025092100102409000_106.8.609.9","unstructured":"Rohman P , Ramaswami U , Mehta A , et al . Three significant milestones and review of the A143T mutation within one family with Anderson-Fabry disease. Nephron Clin Pract 2015;130."},{"key":"2025092100102409000_106.8.609.10","doi-asserted-by":"publisher","DOI":"10.1086\/504601"},{"key":"2025092100102409000_106.8.609.11","unstructured":"Giugliani R , Beck M , Hughes D , et al . Classification of genetic variants in patients with Fabry disease enrolled in Fabry outcome survey (Fos). Poster presented at the 15th Annual WORLD Symposium; February 4-8. 2019, Orlando, Florida, USA, 2019."},{"key":"2025092100102409000_106.8.609.12","first-page":"101","article-title":"Questioning the Pathogenic Role of the GLA p.Ala143Thr \"Mutation\" in Fabry Disease: Implications for Screening Studies and ERT","volume":"8","author":"Terryn","year":"2013","journal-title":"JIMD Rep"},{"key":"2025092100102409000_106.8.609.13","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(15)60953-6","article-title":"Prevalence of clinically apparent hypertrophic cardiomyopathy in 32 patients with the Gla A143T mutation: implications for genetic screening for Fabry disease in patients with hypertrophic cardiomyopathy","volume":"65","author":"Cook","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025092100102409000_106.8.609.14","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.ymgme.2016.11.224","article-title":"Detection of three families with Gla p.A143T mutation and low \u03b1-galactosidase levels by newborn screening for Fabry disease","volume":"120","author":"Marcellus","year":"2017","journal-title":"Mol Genet Metab"},{"key":"2025092100102409000_106.8.609.15","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00336","article-title":"Galactosidase alpha p.A143T variant Fabry disease may result in a phenotype with multifocal microvascular cerebral involvement at a young age","volume":"9","author":"Hauth","year":"2018","journal-title":"Front Neurol"},{"key":"2025092100102409000_106.8.609.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2012.11.003"},{"key":"2025092100102409000_106.8.609.17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cge.12449","article-title":"Diagnostic dilemmas in Fabry disease: a case series study on Gla mutations of unknown clinical significance","volume":"88","author":"Smid","year":"2015","journal-title":"Clin Genet"},{"key":"2025092100102409000_106.8.609.18","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-016-0441-z","article-title":"Alpha-Galactosidase a p.A143T, a non-Fabry disease-causing variant","volume":"11","author":"Lenders","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"2025092100102409000_106.8.609.19","first-page":"729","article-title":"Fabryn tauti","volume":"128","author":"Kantola","year":"2012","journal-title":"Duodecim"},{"key":"2025092100102409000_106.8.609.20","first-page":"41","article-title":"Fabry disease","volume":"19","author":"Golfomitsos","year":"2012","journal-title":"Br J Cardiol"},{"key":"2025092100102409000_106.8.609.21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ehf2.12420","article-title":"Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy","volume":"6","author":"J\u00e4\u00e4skel\u00e4inen","year":"2019","journal-title":"ESC Heart Failure"},{"key":"2025092100102409000_106.8.609.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2003.09.017"},{"key":"2025092100102409000_106.8.609.23","doi-asserted-by":"crossref","unstructured":"Pica S , Sado DM , Maestrini V , et al . Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2014;16.doi:10.1186\/s12968-014-0099-4","DOI":"10.1186\/s12968-014-0099-4"},{"key":"2025092100102409000_106.8.609.24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007168","article-title":"Cardiac phenotype of prehypertrophic Fabry disease","volume":"11","author":"Nordin","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025092100102409000_106.8.609.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.03.020"},{"key":"2025092100102409000_106.8.609.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.09.001"},{"key":"2025092100102409000_106.8.609.27","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12613"},{"key":"2025092100102409000_106.8.609.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.07.741"},{"key":"2025092100102409000_106.8.609.29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00259-015-3036-3","article-title":"First experience of simultaneous PET\/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease","volume":"42","author":"Nappi","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025092100102409000_106.8.609.30","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/ehjci\/jez039","article-title":"Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson\u2013Fabry disease: affinity Study Group","volume":"20","author":"Imbriaco","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2019-315933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:10:37Z","timestamp":1758438637000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2019-315933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,16]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,3,26]]},"published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1136\/heartjnl-2019-315933"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2019-315933","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,16]]}}}